BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 28475688)

  • 1. Oxaliplatin inhibits proliferation and migration of human hepatocellular carcinoma cells via GAS7C and the N-WASP/FAK/F-actin pathway.
    Li D; Zhang B; Hu C
    Acta Biochim Biophys Sin (Shanghai); 2017 Jul; 49(7):581-587. PubMed ID: 28475688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth-arrest-specific 7C protein inhibits tumor metastasis via the N-WASP/FAK/F-actin and hnRNP U/β-TrCP/β-catenin pathways in lung cancer.
    Tseng RC; Chang JW; Mao JS; Tsai CD; Wu PC; Lin CJ; Lu YL; Liao SY; Cheng HC; Hsu HS; Wang YC
    Oncotarget; 2015 Dec; 6(42):44207-21. PubMed ID: 26506240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anti-tumor activities of Neferine on cell invasion and oxaliplatin sensitivity regulated by EMT via Snail signaling in hepatocellular carcinoma.
    Deng G; Zeng S; Ma J; Zhang Y; Qu Y; Han Y; Yin L; Cai C; Guo C; Shen H
    Sci Rep; 2017 Jan; 7():41616. PubMed ID: 28134289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3'3-Diindolylmethane inhibits migration, invasion and metastasis of hepatocellular carcinoma by suppressing FAK signaling.
    Li WX; Chen LP; Sun MY; Li JT; Liu HZ; Zhu W
    Oncotarget; 2015 Sep; 6(27):23776-92. PubMed ID: 26068982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Akebia trifoliata (Thunb.) Koidz Seed Extract inhibits human hepatocellular carcinoma cell migration and invasion in vitro.
    Lu WL; Yang T; Song QJ; Fang ZQ; Pan ZQ; Liang C; Jia DW; Peng PK
    J Ethnopharmacol; 2019 Apr; 234():204-215. PubMed ID: 30528882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ursodeoxycholic acid switches oxaliplatin-induced necrosis to apoptosis by inhibiting reactive oxygen species production and activating p53-caspase 8 pathway in HepG2 hepatocellular carcinoma.
    Lim SC; Choi JE; Kang HS; Han SI
    Int J Cancer; 2010 Apr; 126(7):1582-95. PubMed ID: 19728331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxaliplatin induces apoptosis in hepatocellular carcinoma cells and inhibits tumor growth.
    Wang Z; Zhou J; Fan J; Qiu SJ; Yu Y; Huang XW; Sun J; Tan CJ; Dai Z
    Expert Opin Investig Drugs; 2009 Nov; 18(11):1595-604. PubMed ID: 19780708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ID1 promotes hepatocellular carcinoma proliferation and confers chemoresistance to oxaliplatin by activating pentose phosphate pathway.
    Yin X; Tang B; Li JH; Wang Y; Zhang L; Xie XY; Zhang BH; Qiu SJ; Wu WZ; Ren ZG
    J Exp Clin Cancer Res; 2017 Nov; 36(1):166. PubMed ID: 29169374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salinomycin attenuates liver cancer stem cell motility by enhancing cell stiffness and increasing F-actin formation via the FAK-ERK1/2 signalling pathway.
    Sun J; Luo Q; Liu L; Yang X; Zhu S; Song G
    Toxicology; 2017 Jun; 384():1-10. PubMed ID: 28395993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRC-5 fibroblast-conditioned medium influences multiple pathways regulating invasion, migration, proliferation, and apoptosis in hepatocellular carcinoma.
    Ding S; Chen G; Zhang W; Xing C; Xu X; Xie H; Lu A; Chen K; Guo H; Ren Z; Zheng S; Zhou L
    J Transl Med; 2015 Jul; 13():237. PubMed ID: 26198300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Residual hepatocellular carcinoma after oxaliplatin treatment has increased metastatic potential in a nude mouse model and is attenuated by Songyou Yin.
    Xiong W; Ren ZG; Qiu SJ; Sun HC; Wang L; Liu BB; Li QS; Zhang W; Zhu XD; Liu L; Wang WQ; Tang ZY
    BMC Cancer; 2010 May; 10():219. PubMed ID: 20487542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corosolic Acid Inhibits Hepatocellular Carcinoma Cell Migration by Targeting the VEGFR2/Src/FAK Pathway.
    Ku CY; Wang YR; Lin HY; Lu SC; Lin JY
    PLoS One; 2015; 10(5):e0126725. PubMed ID: 25978354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual sphingosine kinase inhibitor SKI-II enhances sensitivity to 5-fluorouracil in hepatocellular carcinoma cells via suppression of osteopontin and FAK/IGF-1R signalling.
    Grbčić P; Tomljanović I; Klobučar M; Kraljević Pavelić S; Lučin K; Sedić M
    Biochem Biophys Res Commun; 2017 Jun; 487(4):782-788. PubMed ID: 28433634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulated HOXC8 Expression Is Associated with Poor Prognosis and Oxaliplatin Resistance in Hepatocellular Carcinoma.
    Xu P; Zhang X; Ni W; Fan H; Xu J; Chen Y; Zhu J; Gu X; Yang L; Ni R; Chen B; Shi W
    Dig Dis Sci; 2015 Nov; 60(11):3351-63. PubMed ID: 26123838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
    Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
    Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of focal adhesion kinase on the motility, proliferation and apoptosis of Caco2 and SMMC-7721 cells.
    Gao N; He H; Xiao L; Gao X; Shi H; Wu Q; Xu N; Lei Y; Song X; Hou Y
    Med Oncol; 2015 Apr; 32(4):125. PubMed ID: 25790781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sauchinone exerts anticancer effects by targeting AMPK signaling in hepatocellular carcinoma cells.
    Kim YW; Jang EJ; Kim CH; Lee JH
    Chem Biol Interact; 2017 Jan; 261():108-117. PubMed ID: 27871897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic inhibitory effects on hepatocellular carcinoma with recombinant human adenovirus Aspp2 and oxaliplatin via p53-independent pathway in vitro and in vivo.
    Liu X; Xu J; Wang S; Yu X; Kou B; Chai M; Zang Y; Chen D
    Int J Oncol; 2017 Oct; 51(4):1291-1299. PubMed ID: 28902369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JS-K, a nitric oxide prodrug, induces DNA damage and apoptosis in HBV-positive hepatocellular carcinoma HepG2.2.15 cell.
    Liu Z; Li G; Gou Y; Xiao D; Luo G; Saavedra JE; Liu J; Wang H
    Biomed Pharmacother; 2017 Aug; 92():989-997. PubMed ID: 28605880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guadecitabine (SGI-110) priming sensitizes hepatocellular carcinoma cells to oxaliplatin.
    Kuang Y; El-Khoueiry A; Taverna P; Ljungman M; Neamati N
    Mol Oncol; 2015 Nov; 9(9):1799-814. PubMed ID: 26160429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.